# Maybio Matrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/maybio-matrix

- Industry: Materials
- Headquarters: Beijing, China
- Website: www.maybio.cn
- Latest round: Series A (Sep 14, 2023)
- Investors on record: 6

## About

Established in 2019 and based in Beijing, China, Maybio Matrix operates as a pharmaceutical biotechnology company that focuses on the research and development of new materials for regenerating human extracellular matrix. It has a branch in Hunan. Dr. E Xiao, the company's co-founder and chairman, graduated from the University of Pennsylvania. In 2022, the company won the "VB-Find Award for the Top 100 Most Innovative Medical Technology Products (Solutions)". It cooperates with Central South University, Hunan University, Sichuan University, and Nanjing University. In April 2025, Maybio Matrix closed series A++ funding led by new investor Cofoe, with participation from another new investor ZHONGGUANCUN SCIENCE-TECH LEASING CO., LTD.

The company provides regenerative bioscaffold materials for maxillofacial defects and deformity repair in the field of medical aesthetics. It uses human extracellular matrix (ECM) technology to establish a sterile processing production line for prefilled needles. Products are divided into Meiweiti-Ya, Yao, and Nuo series products. Products include collagen hydrating, film-forming excipients, hydrating solutions, collagen gels, collagen freeze-dried fibers and other drugs, medical devices, and cosmetics. ECM products also can be used in myocardium, ligaments, joints, and other fields.

The company generates revenue by providing new ECM regeneration materials, medical and beauty products, and cosmetics.

The company will use the series A++ funding to promote the research and development and industrialization of a series of human extracellular matrix (ECM) regenerative materials, and to promote the clinical registration and commercial promotion of Class III medical devices based on human ECM regenerative materials.

## Funding rounds

- Series A, Sep 14, 2023 — Sunz Fund, Hunan Chasing Fund Management, Beijing New Aerotropolis Fund Management
- Series A, Aug 16, 2021 — Alwin Capital, Century Golden Resources Group, Redhill Capital
- Angel, Jul 9, 2019 — Redhill Capital

## Investors

- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Angel, Series A
- Alwin Capital — Series A
- Century Golden Resources Group — Series A
- Sunz Fund (https://capitalatlas.ai/funds/sunz-fund) — Series A
- Hunan Chasing Fund Management (https://capitalatlas.ai/funds/hunan-chasing-fund-management) — Series A
- Beijing New Aerotropolis Fund Management (https://capitalatlas.ai/funds/beijing-new-aerotropolis-fund-management) — Series A